CSI Market
Sign In | Register

Boston Scientific (BSX) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access BSX Annual Cash Flow →
Cash flow data covering Boston Scientific–Jun 30 2025 offers a view into how Jun 30 2026's cash position has developed alongside business activity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income2,247.00
Depreciation & amortization706.00
Amortization of Other Assets466.00
Impairment charges0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability-35.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories310.00
Equity in loss of uncons. Affiliate0.00
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal0.00
Share-based Compensation170.00
Prepaid expenses0.00
Restructuring charge0.00
Cash Flow Impact Of Deferred Income Tax Expense Benefit-351.00
Purchased Research And Development-
Payment For Contingent Consideration Liability Operating Activities-
Contingent Consideration Expense-
Inventory Step Up Amortization2.00
Net Currency Exchange Gain Loss-
Goodwill And Intangible Asset Impairment-
Income taxes0.00
Gain (Loss) on Investments146.00
Increase (Decrease) in Accounts Receivable163.00
Increase (Decrease) in Accounts Payable and Accrued Liabilities-278.00
Investing losses/ -gains net0.00
Stock compensation0.00
Advance billings and deposits.0.00
Other Working Capital90.00
Restricted stock compensation0.00
Other net-4.00
Payments for (Proceeds from) Other Operating Activities-2,159.00
Discontinued operations0.00
Net Cash flow from Operating Activities1,822.00
Investing Activities
Capital Expenditures-372.00
Sale of Capital Items0.00
Short-term investments liq.0.00
Short-term investments acq.0.00
Payments for (Proceeds from) Hedge, Investing Activities0.00
Proceeds From Divestiture Of Businesses Net Of Costs-
Proceeds From Sales Of Equity Securities And Collections Of Notes Receivable-
Purchases Of Privately Held Securities-
Proceeds From Payments For Investments And Acquisitions Of Certain Technologies61.00
Purchases of other investments0.00
Noncontrolling interest0.00
Proceeds from Investments0.00
Payments for (Proceeds from) Other Investments0.00
Purchases of non-current assets0.00
Payments to Acquire Businesses, Net of Cash Acquired-718.00
Investment in affiliate0.00
Proceeds from Divestiture of Businesses0.00
Proceeds from sale of assets0.00
Payments for (Proceeds from) Loans Receivable, Total0.00
Payments for (Proceeds from) Other Investing Activities43.00
Other Net-1,500.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-2,547.00
Financing Activities
Short-term debt Net1,403.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Noncontrolling interest0.00
Issuances / -repurchases of Comm. Stock-1,914.00
Exercise of stock options0.00
Issuances / -repurchases of Pref. Stock0.00
Discontinued Operations0.00
Other financing activities net8.00
Other net-167.00
Payment Of Contingent Consideration-
Paymenttonetsharesettleemployeeequityawards-85.00
Paymentofcontingentconsiderationinfinancing-
Cashcashequivalentsrestrictedcashandrestrictedcashequivalents Periodincreasedecrease-
Cashcashequivalentsrestrictedcashandrestrictedcashequivalents-
Business Acquisition Contingent Consideration Cash Payment-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents2,147.00
Payments For Royalty Rights-
Proceeds From Secured Borrowings Relating To Royalty Arrangements-
Finance Lease Principal Payments-
Dividends paid to minority interests0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-670.00
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow1,450.00
Total Cash Flow-1,394.00
4 historic quarters locked

Sign in to unlock the full Boston Scientific cash flow history.

Sign In Create Free Account

About Boston Scientific Corp Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 3, 2026
  • Source: bsx-20260630.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000885725-26-000053

Figures are derived from filed reports and may be restated. Historical data is subject to revision.